NextCure (NXTC) Shares Outstanding (2018 - 2026)

NextCure has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $5.3 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 127.15% year-over-year to $5.3 million in Q2 2026; TTM through Jun 2026 was $5.3 million, a 127.15% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 21.79% from the prior year.
• Shares Outstanding (Entity) was $5.3 million for Q2 2026 at NextCure, up from $5.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $5.3 million in Q2 2026, with the low at $2.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $2.7 million, with a median of $2.3 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) rose 0.18% in 2023, then surged 127.15% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $2.3 million in 2022, then advanced by 0.46% to $2.3 million in 2023, then increased by 0.37% to $2.3 million in 2024, then advanced by 21.79% to $2.8 million in 2025, then soared by 86.8% to $5.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $5.3 million (Q2 2026), $5.2 million (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.